Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 1, 2011, Pages 27-32

  Jemec, G B E ^a   Van De Kerkhof, P C M ^b   Enevold, A ^c   Ganslandt, C ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEO PHARMA A S   (Denmark)

Author keywords

betamethasone dipropionate; calcipotriol; psoriasis; scalp

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; PLACEBO; TACLONEX SCALP; UNCLASSIFIED DRUG; XAMIOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SCALP;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SCALP; YOUNG ADULT;

EID: 78649988545     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03682.x     Document Type: Article

References (22)

1. Van De Kerkhof PC, De HD, De KJ, Kuipers MV,. Scalp psoriasis, clinical presentations and therapeutic management. Dermatology 1998; 197: 326-334.
2. Van De Kerkhof PC, Steegers-Theunissen RP, Kuipers MV,. Evaluation of topical drug treatment in psoriasis. Dermatology 1998; 197: 31-36.
3. Poyner T, Fell P,. A survey of patients with plaque psoriasis who had not consulted their doctor in the past year. Br J Clin Res 1995; 6: 201-207.
4. Farber EM, Nall ML,. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148: 1-18.
5. Farber EM, Bright RD, Nall ML,. Psoriasis. A questionnaire survey of 2,144 patients. Arch Dermatol 1968; 98: 248-259.
6. Feldman SR, Housman TS,. Patients' vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol 2003; 4: 221-224.
7. Barnes L, Altmeyer P, Forstrom L, Stenstrom MH,. Long-term treatment of psoriasis with calcipotriol scalp solution and cream. Eur J Dermatol 2000; 10: 199-204.
8. Green C, Ganpule M, Harris D, et al. Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp. Br J Dermatol 1994; 130: 483-487.
9. Thaci D, Daiber W, Boehncke WH, Kaufmann R,. Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients. Dermatology 2001; 203: 153-156.
10. Kragballe K, Van De Kerkhof PC,. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 39-44.
11. Kragballe K, Austad J, Barnes L, et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. Br J Dermatol 2006; 154: 1155-1160.
12. Douglas WS, Poulin Y, Decroix J, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002; 82: 131-135.
13. Kaufmann R, Boehncke WH, Bisssonnette R, et al. A new calcipotriol/betamethasone formulation is a highly effective once-daily treatment for psoriasis vulgaris. Dermatology 2002; 205: 389-393.
14. Papp KA, Guenther L, Boyden B, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003; 48: 48-54.
15. Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S,. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Br J Dermatol 2009; 161: 159-166.
16. Luger TA, Cambazard F, Larsen FG, et al. A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis. Dermatology 2008; 217: 321-328.
17. Tyring S., Bibby A, Foster R,. A 52-week study of a calcipotriol/ betamethasone dipropionate scalp formulation and ointment in the treatment of psoriasis of the scalp and trunk/limbs in hispanic/latino and black/african American patients. 17th Congress of the European Academy of Dermatology and Venereology, Paris, 2008: Abstract no. FP1455. 2008. Ref Type: abstract.
18. Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M,. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study. Dermatology 2008; 217: 107-113.
19. Van De Kerkhof PC, Hoffmann V, Anstey A, et al. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. Br J Dermatol 2009; 160: 170-176.
20. Jemec GB, Ganslandt C, Ortonne JP, et al. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. J Am Acad Dermatol 2008; 59: 455-463.
21. Van De Kerkhof PC, Franssen ME,. Psoriasis of the scalp. Diagnosis and management. Am J Clin Dermatol 2001; 2: 159-165.
22. Koo J,. Vitamin D and scalp psoriasis. Cutis 2002; 70 (Suppl. 5): 21-24.